Dr Louise Segan
MBBS (Hons), FRACP, MPH (Hons)
Dr Louise Segan is a dedicated cardiologist and electrophysiologist, with a profound interest in atrial fibrillation (AF) and heart failure.
She firmly believes in the pivotal role of lifestyle modifications and risk management in altering the trajectory of AF. Embracing a holistic and preventative approach, Dr Segan focuses on individualised risk assessment and reduction strategies in AF management.
Consulting with Cardiology Specialists Melbourne, located within Cabrini Hospital in Malvern, Dr Segan is passionate about and dedicated to improving patient outcomes and access to specialised care.
Dr Segan also supervises the rapid access AF clinic at The Alfred Hospital. This initiative aims to enhance AF education, streamline management, and reduce the time to access specialist care for patients newly diagnosed with AF.
Through her combined efforts in research and clinical practice, Dr Segan aspires to elevate outcomes for patients with AF and heart failure while enhancing communication between clinicians and patients, ultimately fostering better access to specialised care and improving overall quality of life.
Education and Research
Currently serving as a consultation cardiologist and clinical electrophysiology fellow at The Alfred Hospital, Dr Segan is also pursuing a full-time PhD in cardiac electrophysiology at the Baker Heart and Diabetes Institute and the University of Melbourne. Under the guidance of esteemed mentors including Professor Peter Kistler, Professor Jon Kaman, and Associate Professor Sandeep Prabhu, she is delving into research aimed at optimising outcomes for patients with AF and heart failure.
Supported by an NHMRC and National Heart Foundation scholarship, Dr Segan’s research endeavours to concentrate on the recognition of lifestyle modifications’ significance in AF management, alongside interventions to enhance patient outcomes. Leading two ANZCTR registered clinical trials, her work includes the CAMERA-MRI II study, investigating early catheter ablation versus medical rate control in AF and heart failure, and the WITHDRAW-AF study, exploring the safety and feasibility of staged withdrawal of neurohormonal therapies in patients with rhythm-controlled AF and recovered AF-mediated cardiomyopathy.
Achievements
Dr Segan’s contributions have garnered recognition, including prestigious accolades such as the Paul Korner Medal for Outstanding Achievement at the Baker Institute, the ISHR Australasia ECIC Carer Award, the Baker Institute Symposium Rod Andrews Prize, and the CSANZ Prevention Prize.
Additional References